<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e>-promoting <z:chebi fb="0" ids="37532">phorbol esters</z:chebi>, like growth factors, elicit pleiotropic responses involving biochemical pathways that lead to different biological responses </plain></SENT>
<SENT sid="1" pm="."><plain>Genetic variant cell lines that are resistant to mitogenic, differentiation, or transformation responses to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> promoters have been valuable tools for understanding the molecular bases of these responses </plain></SENT>
<SENT sid="2" pm="."><plain>Studies using the mouse epidermal JB6 cell lines that are sensitive or resistant to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> promoter-induced transformation have yielded new understanding of genetic and signal transduction events involved in <z:e sem="disease" ids="C0007621" disease_type="Neoplastic Process" abbrv="">neoplastic transformation</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The isolation and characterization of cloned mouse promotion sensitivity genes pro-1 and pro-2 is reviewed </plain></SENT>
<SENT sid="4" pm="."><plain>A new activity of pro-1 has been identified: when transfected into human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prone <z:hpo ids='HP_0002671'>basal cell nevus</z:hpo> syndrome fibroblasts but not <z:mpath ids='MPATH_458'>normal</z:mpath> fibroblasts mouse pro-1 confers lifespan extension on these cells </plain></SENT>
<SENT sid="5" pm="."><plain>Recently, we have found that a pro-1 homolog from a library of nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp>, but not the homolog from a <z:mpath ids='MPATH_458'>normal</z:mpath> human library, is activated for transferring promotion sensitivity </plain></SENT>
<SENT sid="6" pm="."><plain>The many genetic variants for responses to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> promoters have also proved valuable for signal transduction studies </plain></SENT>
<SENT sid="7" pm="."><plain>JB6 P- cells fail to show the 12-O-<z:chebi fb="0" ids="25456">tetradecanoyl</z:chebi>-<z:chebi fb="0" ids="45127">phorbol-13-acetate</z:chebi> (<z:chebi fb="6" ids="15702,53394">TPA</z:chebi>)-induced synthesis of two proteins of 15 and 16 kD seen in P+ cells </plain></SENT>
<SENT sid="8" pm="."><plain>P-, P+, and <z:chebi fb="6" ids="15702,53394">TPA</z:chebi> transformed cells show a progressive decrease in both basal and <z:chebi fb="6" ids="15702,53394">TPA</z:chebi>-inducible levels of a protein kinase C substrate of 80 kD </plain></SENT>
<SENT sid="9" pm="."><plain>P- cells are relatively resistant both to anchorage-independent transformation and to a protein band shift induced by the calcium analog <z:chebi fb="3" ids="33336">lanthanum</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>It appears that one or more calcium-binding proteins and one or more pro genes may be critical determinants of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> promoter-induced <z:e sem="disease" ids="C0007621" disease_type="Neoplastic Process" abbrv="">neoplastic transformation</z:e> </plain></SENT>
</text></document>